On May 8, 2015, an affidavit or declaration regarding motion for approval of procedures regarding voting on a plan of reorganization or liquidation was filed in the bankruptcy case of New England Compounding Pharmacy, Inc. and its affiliates.
The filing was assigned docket number 1294 and is described on the court’s official docket as follows:
Chapter 11 Ballots /Declaration of Jung W. Song on Behalf of Donlin, Recano & Company, Inc. Regarding Voting and Tabulation of Ballots Accepting and Rejecting the First Amended Joint Chapter 11 Plan of New England Compounding Pharmacy, Inc. filed by Trustee Paul D. Moore (Lastowski, Michael)
New England Compounding Pharmacy, Inc. filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on December 21, 2012. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Massachusetts. The case number for the lead bankruptcy case is 12-19882. The bankruptcy case is currently assigned to United States Bankruptcy Judge Henry Boroff. The law firm of Murtha Cullina LLP is acting as lead bankruptcy counsel to New England Compounding Pharmacy, Inc. in the bankruptcy case.